<i>In vivo</i> dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer-Reference-Cited by-同舟云学术

In vivo dynamics and anti-tumor effects of EpCAM-directed CAR T-cells against brain metastases from lung cancer

Published:2023-01-13 Issue:1 Volume:12 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Xu Tao¹,Karschnia Philipp²³,Cadilha Bruno Loureiro⁴,Dede Sertac¹,Lorenz Michael⁵,Seewaldt Niklas²,Nikolaishvili Elene²,Müller Katharina¹,Blobner Jens²³,Teske Nico²³,Herold Julika J.²,Rejeski Kai³⁶,Langer Sigrid¹,Obeck Hannah⁴,Lorenzini Theo⁴,Mulazzani Matthias⁷,Zhang Wenlong¹,Ishikawa-Ankerhold Hellen⁵,Buchholz Veit R.⁸,Subklewe Marion⁶,Thon Niklas²³,Straube Andreas¹,Tonn Joerg-Christian²³,Kobold Sebastian⁴,von Baumgarten Louisa¹²³

Affiliation:

1. Department of Neurology, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany

2. Department of Neurosurgery, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany

3. German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany

4. Department of Medicine IV, Division of Clinical Pharmacology and Center of Integrated Protein Science Munich, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany

5. Department of Medicine I, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany

6. Department of Medicine III, University Hospital of the Ludwig-Maximilians-University Munich, Munich, Germany

7. Immunology Division, Walter and Eliza Hall Institute of Medical Research, Parkville, Australia

8. Institute for Medical Microbiology, Immunology and Hygiene, Technische Universitaet Muenchen (TUM), Munich, Germany

Funder

Friedrich-Baur-Foundation

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2022.2163781

Reference41 articles.

1. Brain metastases

2. First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer

3. The evolving role of neurosurgery for central nervous system metastases in the era of personalized cancer therapy

4. Pembrolizumab for management of patients with NSCLC and brain metastases: long-term results and biomarker analysis from a non-randomised, open-label, phase 2 trial

5. Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell Therapy

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Harnessing immunotherapy for brain metastases: insights into tumor–brain microenvironment interactions and emerging treatment modalities;Journal of Hematology & Oncology;2023-12-16

2. New T-Cell Therapies for Brain Metastasis, CD133 in the Driver's Seat;Clinical Cancer Research;2023-12-01

3. Chimeric Antigen Receptor-T Cell and Oncolytic Viral Therapies for Gastric Cancer and Peritoneal Carcinomatosis of Gastric Origin: Path to Improving Combination Strategies;Cancers;2023-11-30

4. <i>In vivo</i> models in cancer research;Advances in Molecular Oncology;2023-07-10

5. Neurotoxicity and management of primary and secondary central nervous system lymphoma after adoptive immunotherapy with CD19-directed chimeric antigen receptor T-cells;Neuro-Oncology;2023-07-04